 |
| Kathryn Metcalfe |
Bristol-Myers Squibb has named healthcare PR veteran Kathryn Metcalfe executive VP, corporate affairs, effective Jan. 6.
Metcalfe goes to BMS from CVS Health, where she was chief communications officer. She previously served as CCO at both Aetna and Deloitte, held VP posts at Pfizer and Novartis and helmed Cohn & Wolfe's New York office.
Metcalfe “will play an important role on the leadership team as we engage with a broad range of stakeholders around our business, the promise of our pipeline and the exciting opportunities we are pursuing for patients,” said BMS chief and CEO Giovanni Caforio.
Metcalfe’s appointment follows the announcement that BMS executive VP, corporate affairs & investor relations John Elicker will be retiring on March 31.
Tim Power, who is currently lead for IR, will take on the position of VP & IR chief upon Elicker’s retirement.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
